
MENAP SCI Supports the Launch of the African Medicines Agency Treaty Alliance (AMATA)
Access to safe, effective, and high-quality medicines is a fundamental right, yet millions across Africa face barriers due to regulatory challenges and substandard treatments. The launch of the African Medicines Agency Treaty Alliance (AMATA) marks a significant step toward ensuring better healthcare for all. As advocates for scientific progress and public health, MENAP SCI stands in support of this critical initiative.
Strengthening Self-Care Through Regulatory Excellence
The African Medicines Agency (AMA) treaty aims to harmonize medicine regulations across Africa, ensuring that life-saving treatments are accessible and reliable. With strong regulatory frameworks, communities can benefit from safer pharmaceuticals, fostering better self-care and disease management.
A Collective Call for Action
Patient advocacy groups, pharmacy associations, and business leaders are rallying for African Heads of State and Government to ratify the AMA treaty. By doing so, they will enable a healthier future through improved medicine quality and innovation.
MENAP SCI recognizes the importance of regional collaboration in advancing global health standards. We encourage all stakeholders to support this initiative and work together toward a healthier, more resilient future.